Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4647 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.53 USD | 0.00% | -0.78% | +2.02% | +20.48% | 11.19 M USD | ||
| 4650 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.94 USD | -4.08% | +17.50% | +10.59% | -58.22% | 11.12 M USD | ||
| 4651 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.25 USD | 0.00% | -13.79% | +4.17% | -51.92% | 11.09 M USD | ||
| 4653 |  TOVX Theriva Biologics, Inc. Common Stock | 0.24 USD | -4.00% | +4.35% | -4.00% | -4.00% | 11.01 M USD | ||
| 4659 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.20 USD | +2.56% | -19.46% | -37.50% | -49.37% | 10.81 M USD | ||
| 4661 |  GTBP GT Biopharma, Inc. - Common Stock | 5.95 USD | -4.03% | -6.45% | -2.94% | +682.89% | 10.74 M USD | ||
| 4664 |  LTRN Lantern Pharma Inc. - Common Stock | 0.83 USD | -8.79% | -18.63% | -52.02% | -80.19% | 10.61 M USD | ||
| 4668 |  ADIL Adial Pharmaceuticals, Inc - Common Stock | 3.97 USD | -0.50% | -12.17% | -33.16% | +845.24% | 10.42 M USD | ||
| 4679 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.39 USD | +2.21% | +6.92% | -47.94% | -6.08% | 10.00 M USD | ||
| 4681 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.32 USD | -3.03% | +3.23% | 0.00% | -66.32% | 9.97 M USD | ||
| 4693 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.22 USD | +0.45% | -4.72% | -12.25% | -21.00% | 9.66 M USD | ||
| 4695 |  BIVI BioVie Inc. - Common stock | 1.28 USD | -8.57% | -12.93% | -34.36% | +1.59% | 9.65 M USD | ||
| 4704 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.46 USD | +6.98% | +12.20% | -4.17% | +21.05% | 8.95 M USD | ||
| 4705 |  QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 4.55 USD | -3.19% | -5.41% | -33.48% | -51.18% | 9.14 M USD | ||
| 4708 |  IMRN Immuron Limited - American Depositary Shares | 1.11 USD | +1.83% | -0.89% | -35.47% | -47.64% | 8.96 M USD | ||
| 4711 |  MTVA MetaVia Inc. - Common Stock | 1.34 USD | -8.22% | -14.10% | -23.43% | +28.85% | 8.83 M USD | ||
| 4735 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.42 USD | -4.55% | -17.65% | -46.84% | -86.67% | 8.18 M USD | ||
| 4741 |  AZTR Azitra Inc Common Stock | 0.13 USD | 0.00% | 0.00% | -27.78% | -18.75% | 7.88 M USD | ||
| 4744 |  CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.35 USD | -1.47% | +2.29% | -7.60% | -45.80% | 7.82 M USD | ||
| 4751 |  SNGX Soligenix, Inc. - Common Stock | 0.35 USD | 0.00% | -5.41% | -2.78% | -69.03% | 7.62 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |